Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma
Authors
Keywords
-
Journal
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
Volume 9, Issue 4, Pages e1439
Publisher
Wiley
Online
2016-11-04
DOI
10.1002/wnan.1439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Central Nervous System Cancers, Version 2.2014
- (2017) Louis Burt Nabors et al. Journal of the National Comprehensive Cancer Network
- Nanoparticles: Novel vehicles in treatment of Glioblastoma
- (2016) Fatemeh Pourgholi et al. BIOMEDICINE & PHARMACOTHERAPY
- Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
- (2016) David S. Hersh et al. CURRENT PHARMACEUTICAL DESIGN
- Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer
- (2015) Atul Jain et al. Acta Biomaterialia
- Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells
- (2015) Craig S. Schneider et al. BIOMATERIALS
- The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo
- (2015) Houmam Kafa et al. BIOMATERIALS
- Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
- (2015) Sang-Soo Kim et al. CANCER LETTERS
- Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle
- (2015) P. M. Peiris et al. CANCER RESEARCH
- Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma
- (2015) Kyle T. Householder et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics
- (2015) Craig S. Schneider et al. JOURNAL OF CONTROLLED RELEASE
- Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles
- (2015) Alexandros Bouras et al. JOURNAL OF NEURO-ONCOLOGY
- A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
- (2015) Sang-Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
- (2015) J G Perez et al. ONCOGENE
- Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection
- (2015) Rainer Schulz et al. PHARMACOLOGY & THERAPEUTICS
- Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
- (2015) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
- (2015) Marc Aubry et al. Oncotarget
- Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
- (2015) Milota Kaluzova et al. Oncotarget
- Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
- (2015) Nicole Renee Parker et al. Frontiers in Oncology
- Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
- (2015) Emily Padfield et al. Frontiers in Oncology
- Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid
- (2015) Manuela Porru et al. Oncotarget
- A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
- (2014) Sang-Soo Kim et al. ACS Nano
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
- (2014) Melanie Jackson et al. CARCINOGENESIS
- Regulation of Fibroblast Growth Factor-inducible 14 (Fn14) Expression Levels via Ligand-independent Lysosomal Degradation
- (2014) Sujatha Gurunathan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
- (2014) Stephanie Tortorella et al. JOURNAL OF MEMBRANE BIOLOGY
- In Vivo Imaging of Brain Cancer Using Epidermal Growth Factor Single Domain Antibody Bioconjugated to Near-Infrared Quantum Dots
- (2014) D. Fatehi et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Neurosurgical oncology: advances in operative technologies and adjuncts
- (2014) Randy S. D’Amico et al. JOURNAL OF NEURO-ONCOLOGY
- Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: Potential for targeting experimental brain tumors
- (2014) Roberto Jose Diaz et al. Nanomedicine-Nanotechnology Biology and Medicine
- MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
- (2014) B. J. Gill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Emerging Insights into Barriers to Effective Brain Tumor Therapeutics
- (2014) Graeme F. Woodworth et al. Frontiers in Oncology
- Noninvasive and Targeted Drug Delivery to the Brain Using Focused Ultrasound
- (2013) Alison Burgess et al. ACS Chemical Neuroscience
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel
- (2013) Xinyi Jiang et al. BIOMATERIALS
- Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment
- (2013) Xinyi Jiang et al. BIOMATERIALS
- Transferrin-Modified Doxorubicin-Loaded Biodegradable Nanoparticles Exhibit Enhanced Efficacy in Treating Brain Glioma-Bearing Rats
- (2013) Guodong Liu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
- (2013) Daniel J. Wolak et al. MOLECULAR PHARMACEUTICS
- The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells
- (2013) Sang-Soo Kim et al. MOLECULAR THERAPY
- Development, maintenance and disruption of the blood-brain barrier
- (2013) Birgit Obermeier et al. NATURE MEDICINE
- TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
- (2013) Emily Cheng et al. Frontiers in Immunology
- Glioblastoma: Molecular Analysis and Clinical Implications
- (2012) Jason T. Huse et al. Annual Review of Medicine
- A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas
- (2012) Yan Li et al. BIOMATERIALS
- Glioblastoma cancer stem cells – From concept to clinical application
- (2012) Barbara E. Stopschinski et al. CANCER LETTERS
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- The Role of Pericytes in Blood-Brain Barrier Function and Stroke
- (2012) Shuo Liu et al. CURRENT PHARMACEUTICAL DESIGN
- Cdc42 and the Guanine Nucleotide Exchange Factors Ect2 and Trio Mediate Fn14-Induced Migration and Invasion of Glioblastoma Cells
- (2012) S. P. Fortin et al. MOLECULAR CANCER RESEARCH
- Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system
- (2012) Suwussa Bamrungsap et al. Nanomedicine
- A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
- (2012) E. A. Nance et al. Science Translational Medicine
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- Glioblastoma: From Molecular Pathology to Targeted Treatment
- (2011) Timothy F. Cloughesy et al. Annual Review of Pathology-Mechanisms of Disease
- Enhanced Intracellular Delivery and Chemotherapy for Glioma Rats by Transferrin-Conjugated Biodegradable Polymersomes Loaded with Doxorubicin
- (2011) Zhiqing Pang et al. BIOCONJUGATE CHEMISTRY
- Advances in the field of nanooncology
- (2011) KK Jain BMC Medicine
- Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke
- (2011) Kim M. Baeten et al. Developmental Neurobiology
- Silencing IL-13R 2 Promotes Glioblastoma Cell Death via Endogenous Signaling
- (2011) L. C. Hsi et al. MOLECULAR CANCER THERAPEUTICS
- Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43
- (2011) Vladimir P. Chekhonin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells
- (2011) Jiang Chang et al. PHARMACEUTICAL RESEARCH
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Recombinant human transferrin: Beyond iron binding and transport
- (2010) Martin E. Brandsma et al. BIOTECHNOLOGY ADVANCES
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
- (2010) C. G. Hadjipanayis et al. CANCER RESEARCH
- Strategy for effective brain drug delivery
- (2010) M. Intakhab Alam et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
- (2010) Shailendra Joshi et al. JOURNAL OF NEURO-ONCOLOGY
- Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma Rats
- (2010) Zhiqing Pang et al. MOLECULAR PHARMACEUTICS
- Pericytes regulate the blood–brain barrier
- (2010) Annika Armulik et al. NATURE
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- The Pathobiology of Glioma Tumors
- (2009) Candece L. Gladson et al. Annual Review of Pathology-Mechanisms of Disease
- Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
- (2009) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
- (2009) Hemant Sarin et al. Journal of Translational Medicine
- Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
- (2009) A. B. Madhankumar et al. MOLECULAR CANCER THERAPEUTICS
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- Biology of angiogenesis and invasion in glioma
- (2009) Matthew C. Tate et al. Neurotherapeutics
- Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
- (2009) Cameron Brennan et al. PLoS One
- RGD-labeled USPIO Inhibits Adhesion and Endocytotic Activity of αvβ3-Integrin–expressing Glioma Cells and Only Accumulates in the Vascular Tumor Compartment
- (2009) Fabian Kiessling et al. RADIOLOGY
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme
- (2008) David A Reardon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffusion in Brain Extracellular Space
- (2008) Eva Syková et al. PHYSIOLOGICAL REVIEWS
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors
- (2007) Beata Chertok et al. BIOMATERIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started